BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+48.27%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$152M
AUM Growth
–
Cap. Flow
+$152M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$80.6M |
| 2 |
InflaRx
IFRX
|
$39.3M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$32.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 25.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $80.6M | 52.91% | +8,930,237 | New | +$80.6M |
|
|
2
InflaRx
IFRX
$108M
| $39.3M | 25.79% | +1,876,413 | New | +$39.3M |
|
|
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $32.5M | 21.3% | +3,977,453 | New | +$32.5M |
|